Transforming growth factor beta (TGF beta) activity in urine of patients with glomerulonephritis.
Several lines of experimental evidence have shown that transforming growth factor beta (TGF beta) may play major role in glomerular diseases, mediating the inflammatory response through glomerulosclerosis. In the present study we evaluated TGF beta activity in occasional urine samples from 7 normal individuals and from 15 patients (10 with focal glomerular sclerosis and 5 with membranous glomerulonephritis) using a CCL-64 mink lung cell growth inhibition assay. Urinary TGF beta activity (reported in relation to urine creatinine concentration, Ucr, mean +/- SD) was higher in patients with focal glomerular sclerosis (mean = 17.32 +/- 15.75/10 micrograms Ucr) and patients with membranous glomerulonephritis (mean = 17.78 +/- 11.53/10 micrograms Ucr) than in normal individuals (mean = 0.8 +/- 0.44/10 micrograms Ucr). We also observed that TGF beta activity in urine from patients with focal glomerular sclerosis correlated with their plasma creatinine levels (r = 0.85), suggesting that TGF beta activity may be correlated with other indices of disease progression. Our data suggest that measurement of urinary TGF beta activity could be a useful noninvasive procedure for the evaluation of renal TGF beta production, which may be useful to assess prognosis and to evaluate therapeutic efficacy in patients with renal disease.
Dominguez
G C
GC
Departamento de Clínica Médica, Faculdade de Medicine de Ribeirão Preto, Universidade de São Paulo, Brasil.
Costa
R S
RS
Dantas
M
M
Kimachi
T
T
Coimbra
T M
TM
D003404:Creatinine / Q000097:blood; D005921:Glomerulonephritis / Q000652:urine*; D005923:Glomerulosclerosis, Focal Segmental / Q000652:urine*; D006801:Humans; D016014:Linear Models; D011379:Prognosis; D016212:Transforming Growth Factor beta / Q000652:urine*
D016212:Transforming Growth Factor beta; D003404:Creatinine